BRIVARACETAM ORAL SOLUTION

BRIVARACETAM ORAL SOLUTION is FDA application ANDA220385, sponsored by REGCON HOLDINGS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.